These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29224172)

  • 1. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
    Silva DMW; Borba VZC; Kanis JA
    Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hip fracture in Brazil and the development of a FRAX model.
    Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
    Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Brazilian Fracture Assessment Risk Tool (FRAX) model and the age-dependent intervention thresholds according to National Osteoporosis Guideline Group (NOGG) guidelines on fracture prediction in community-dwelling older adults: the São Paulo Ageing and Health (SPAH) Study.
    Freitas TQ; Olalla LFG; Machado LG; Figueiredo CP; Takayama L; de Falco Caparbo V; Domiciano DS; Pereira RMR
    Arch Osteoporos; 2024 Jul; 19(1):59. PubMed ID: 38990403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
    Bastos-Silva Y; Aguiar LB; Pinto-Neto AM; Baccaro LF; Costa-Paiva L
    Arch Osteoporos; 2016; 11():16. PubMed ID: 27067597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
    Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
    Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.
    Liu SY; Huang M; Chen R; Ding N; Liu H; Xie ZJ; Sheng ZF; Luo BH; Ou YN
    Endocrine; 2019 Jul; 65(1):200-206. PubMed ID: 31111436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women.
    Chandran M; McCloskey EV; Thu WPP; Logan S; Hao Y; Tay D; Ang WC; Aung TKK; Choo KS; Ali A; Yan SX; Huang XF; Liu XM; Yong EL; Lekamwasam S
    Arch Osteoporos; 2018 Nov; 13(1):130. PubMed ID: 30456726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka.
    Lekamwasam S; Chandran M; Subasinghe S
    Arch Osteoporos; 2019 Mar; 14(1):33. PubMed ID: 30850909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.
    Aw D; Thain J; Ali A; Aung T; Chua WM; Sahota O; Weerasuriya N; Marshall L; Kearney F; Masud T
    Postgrad Med J; 2016 May; 92(1087):267-70. PubMed ID: 26792635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
    McCloskey EV; Johansson H; Harvey NC; Compston J; Kanis JA
    Osteoporos Int; 2017 Jan; 28(1):71-76. PubMed ID: 27438128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry.
    Crandall CJ; Schousboe JT; Morin SN; Lix LM; Leslie W
    J Bone Miner Res; 2019 Aug; 34(8):1419-1427. PubMed ID: 30920022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
    Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
    Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX®: a north Italian multicenter study.
    Pedrazzoni M; Girasole G; Giusti A; Barone A; Pioli G; Passeri G; Palummeri E; Bianchi G
    J Endocrinol Invest; 2011 Dec; 34(11):e386-91. PubMed ID: 21750394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
    Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
    Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk.
    Dimai HP; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; Fahrleitner-Pammer A; Pietschmann P; Muschitz C; McCloskey EV; Kanis JA
    Arch Osteoporos; 2022 Nov; 17(1):141. PubMed ID: 36357621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Chakhtoura M; Leslie WD; McClung M; Cheung AM; Fuleihan GE
    Osteoporos Int; 2017 Jan; 28(1):127-137. PubMed ID: 27650643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
    Lippuner K
    Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study.
    Ensrud KE; Taylor BC; Peters KW; Gourlay ML; Donaldson MG; Leslie WD; Blackwell TL; Fink HA; Orwoll ES; Schousboe J;
    BMJ; 2014 Jul; 349():g4120. PubMed ID: 24994809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of FRAX-based osteoporosis intervention using real world data.
    Goldshtein I; Ish-Shalom S; Leshno M
    Bone; 2017 Oct; 103():318-324. PubMed ID: 28778597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Kamycheva E; Goto T; Camargo CA
    Osteoporos Int; 2017 Mar; 28(3):781-790. PubMed ID: 27714440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.